BofA Securities Upgrades Vir Biotechnology (VIR) to Buy, 'Underappreciated HDV opportunity, TCEs essentially free'

Go back to BofA Securities Upgrades Vir Biotechnology (VIR) to Buy, 'Underappreciated HDV opportunity, TCEs essentially free'
(NASDAQ: VIR) Delayed: 9.24 +0.24 (2.67%)
Previous Close $9.00    52 Week High
Open $9.00    52 Week Low
Day High $9.27    P/E N/A 
Day Low $8.80    EPS
Volume 1,016,285